These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 24157876)

  • 1. LHX6 acts as a novel potential tumour suppressor with epigenetic inactivation in lung cancer.
    Liu WB; Jiang X; Han F; Li YH; Chen HQ; Liu Y; Cao J; Liu JY
    Cell Death Dis; 2013 Oct; 4(10):e882. PubMed ID: 24157876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic inactivation of LHX6 mediated microcystin-LR induced hepatocarcinogenesis via the Wnt/β-catenin and P53 signaling pathways.
    Chen HQ; Zhao J; Li Y; Huang YJ; Chen DJ; He LX; Wang LQ; Zheng CF; Wang J; Cao J; Shu WQ; Liu JY; Liu WB
    Environ Pollut; 2019 Sep; 252(Pt A):216-226. PubMed ID: 31151060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic silencing of Aristaless-like homeobox-4, a potential tumor suppressor gene associated with lung cancer.
    Liu WB; Han F; Du XH; Jiang X; Li YH; Liu Y; Chen HQ; Ao L; Cui ZH; Cao J; Liu JY
    Int J Cancer; 2014 Mar; 134(6):1311-22. PubMed ID: 24037716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inactivation of ADAMTS18 by aberrant promoter hypermethylation contribute to lung cancer progression.
    Zhang Y; Xu H; Mu J; Guo S; Ye L; Li D; Peng W; He X; Xiang T
    J Cell Physiol; 2019 May; 234(5):6965-6975. PubMed ID: 30417422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation-mediated silencing of the LIM homeobox 6 (LHX6) gene promotes cell proliferation in human pancreatic cancer.
    Abudurexiti Y; Gu Z; Chakma K; Hata T; Motoi F; Unno M; Horii A; Fukushige S
    Biochem Biophys Res Commun; 2020 Jun; 526(3):626-632. PubMed ID: 32248980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
    Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
    Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic Silencing of LMX1A Contributes to Cancer Progression in Lung Cancer Cells.
    Wu TH; Chang SY; Shih YL; Chian CF; Chang H; Lin YW
    Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LHX6 inhibits the proliferation, invasion and migration of breast cancer cells by modulating the PI3K/Akt/mTOR signaling pathway.
    Bi QJ; Men XJ; Han R; Li GL
    Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3067-3073. PubMed ID: 29863252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway.
    Hu Z; Xie L
    Mol Med Rep; 2015 Sep; 12(3):4634-4639. PubMed ID: 26129710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia.
    Kuang SQ; Fang Z; Zweidler-McKay PA; Yang H; Wei Y; Gonzalez-Cervantes EA; Boumber Y; Garcia-Manero G
    PLoS One; 2013; 8(4):e61807. PubMed ID: 23637910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ECRG4 acts as a tumor suppressor gene frequently hypermethylated in human breast cancer.
    Tang GY; Tang GJ; Yin L; Chao C; Zhou R; Ren GP; Chen JY; Zhang W
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30918105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
    Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
    Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer.
    Han F; Liu W; Jiang X; Shi X; Yin L; Ao L; Cui Z; Li Y; Huang C; Cao J; Liu J
    Oncogene; 2015 Aug; 34(33):4391-402. PubMed ID: 25435374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMEM196 acts as a novel functional tumour suppressor inactivated by DNA methylation and is a potential prognostic biomarker in lung cancer.
    Liu WB; Han F; Jiang X; Chen HQ; Zhao H; Liu Y; Li YH; Huang C; Cao J; Liu JY
    Oncotarget; 2015 Aug; 6(25):21225-39. PubMed ID: 26056045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
    Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
    Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of tumor-suppressor gene LHX6 in cancer: a systematic review.
    Nathalia E; Theardy MS; Elvira S; Rosellinny G; Liyanto AS; Utama MP; Sumarpo A
    Rom J Intern Med; 2018 Sep; 56(3):135-142. PubMed ID: 29533904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic downregulation of RUNX3 by DNA methylation induces docetaxel chemoresistance in human lung adenocarcinoma cells by activation of the AKT pathway.
    Zheng Y; Wang R; Song HZ; Pan BZ; Zhang YW; Chen LB
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2369-78. PubMed ID: 23892093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.
    Scherf DB; Sarkisyan N; Jacobsson H; Claus R; Bermejo JL; Peil B; Gu L; Muley T; Meister M; Dienemann H; Plass C; Risch A
    Oncogene; 2013 Jul; 32(28):3329-38. PubMed ID: 22945651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NDN is an imprinted tumor suppressor gene that is downregulated in ovarian cancers through genetic and epigenetic mechanisms.
    Yang H; Das P; Yu Y; Mao W; Wang Y; Baggerly K; Wang Y; Marquez RT; Bedi A; Liu J; Fishman D; Lu Z; Bast RC
    Oncotarget; 2016 Jan; 7(3):3018-32. PubMed ID: 26689988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PON1 hypermethylation is associated with progression of renal cell carcinoma.
    Li X; Yu Q
    J Cell Mol Med; 2019 Oct; 23(10):6646-6657. PubMed ID: 31400051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.